Elbit Systems Awarded $1.635 Billion Contract to Deliver a Range of Defense Solutions to a European Country
The contract includes two groups of technologically advanced solutions from Elbit Systems. These solutions are based on the Company's cutting-edge technologies and portfolio and include embedded AI technology, among others.
The first group includes long-range precision strike artillery-rocket systems and a broad-spectrum of unmanned reconnaissance and loitering aerial combat systems, from operational to tactical ranges, including personally operated drones.
The second group includes, among others, highly sophisticated ISTAR capabilities, including SIGINT, COMINT and electronic warfare systems. Enabled intelligence collection and processing systems will also be delivered, along with advanced electro-optical (E/O) and night-vision systems, combat vehicle upgrade, and protective systems. In addition, Elbit Systems will deliver comprehensive military digitalization and Network Combat Solution, based on the last software generation and cutting-edge hardware communication equipment. This includes intelligence solutions from the C4ISR suite of command-and-control applications. This integrated solution covers all operational levels, spanning from the strategic army headquarters down to the tactical level, to the last combat vehicle.
Bezhalel (Butzi) Machlis, President and CEO of Elbit Systems: "This contract reflects the strong demand for Elbit Systems' cutting-edge technologies in Europe and demonstrates our ability to deliver integrated, multi-domain solutions tailored to the needs of modern defense forces. Elbit Systems' comprehensive portfolio has proven itself operationally in the battlefield and is highly regarded by its users, and we are proud to support a European nation in strengthening its national security through this strategic partnership. This contract also includes industrial cooperation aimed to strengthen the buyer's national industrial capabilities in the mentioned areas."
About Elbit Systems
Elbit Systems is a leading global defense technology company, delivering advanced solutions for a secure and safer world. Elbit Systems develops, manufactures, integrates and sustains a range of next-generation solutions across multiple domains.
Driven by its agile, collaborative culture, and leveraging Israel's technology ecosystem, Elbit Systems enables customers to address rapidly evolving battlefield challenges and overcome threats.
Elbit Systems employs approximately 20,000 people in dozens of countries across five continents. The Company reported $1.9 billion in revenues for the three months ended March 31, 2025 and an order backlog of $23.1 billion as of such date.
For additional information, visit: https://elbitsystems.com, follow us on Twitter or visit our official Facebook, YouTube and LinkedIn Channels.
Company Contact: Dr. Yaacov (Kobi) Kagan, Executive VP - CFOTel: +972-77-2946663kobi.kagan@elbitsystems.com
Daniella Finn, VP, Investor RelationsTel: +972-77-2948984daniella.finn@elbitsystems.com
Dalia Bodinger, VP, Communications & BrandTel: +972-77-2947602dalia.bodinger@elbitsystems.com
This press release may contain forward–looking statements (within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Israeli Securities Law, 1968) regarding Elbit Systems Ltd. and/or its subsidiaries (collectively the Company), to the extent such statements do not relate to historical or current facts. Forward-looking statements are based on management's current expectations, estimates, projections and assumptions about future events. Forward–looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions about the Company, which are difficult to predict, including projections of the Company's future financial results, its anticipated growth strategies and anticipated trends in its business. Therefore, actual future results, performance and trends may differ materially from these forward–looking statements due to a variety of factors, including, without limitation: scope and length of customer contracts; governmental regulations and approvals; changes in governmental budgeting priorities; general market, political and economic conditions in the countries in which the Company operates or sells, including Israel and the United States, among others, including the duration and scope of the current war in Israel, and the potential impact on our operations; changes in global health and macro-economic conditions; differences in anticipated and actual program performance, including the ability to perform under long-term fixed-price contracts; changes in the competitive environment; and the outcome of legal and/or regulatory proceedings. The factors listed above are not all-inclusive, and further information is contained in Elbit Systems Ltd.'s latest annual report on Form 20-F, which is on file with the U.S. Securities and Exchange Commission. All forward–looking statements speak only as of the date of this release. Although the Company believes the expectations reflected in the forward-looking statements contained herein are reasonable, it cannot guarantee future results, level of activity, performance or achievements. Moreover, neither the Company nor any other person assumes responsibility for the accuracy and completeness of any of these forward-looking statements. The Company does not undertake to update its forward-looking statements.
Elbit Systems Ltd., its logo, brand, product, service and process names appearing in this release are the trademarks or service marks of Elbit Systems Ltd. or its affiliated companies. All other brand, product, service and process names appearing are the trademarks of their respective holders. Reference to or use of a product, service or process other than those of Elbit Systems Ltd. does not imply recommendation, approval, affiliation or sponsorship of that product, service or process by Elbit Systems Ltd. Nothing contained herein shall be construed as conferring by implication, estoppel or otherwise any license or right under any patent, copyright, trademark or other intellectual property right of Elbit Systems Ltd. or any third party, except as expressly granted herein.
Logo: https://mma.prnewswire.com/media/2017806/Elbit_Systems_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/elbit-systems-awarded-1-635-billion-contract-to-deliver-a-range-of-defense-solutions-to-a-european-country-302528702.html
SOURCE Elbit Systems Ltd.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
10 minutes ago
- Yahoo
Global-e Reports Second Quarter 2025 Results
PETAH-TIKVA, Israel, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Global-e Online Ltd. (Nasdaq: GLBE) the platform powering global direct-to-consumer e-commerce, today reported financial results for the second quarter of 2025. 'We had another strong quarter, meeting or exceeding all of our guidance ranges, on-boarding many new and exciting merchants, and achieving an important milestone of sustainable GAAP profitability,' said Amir Schlachet, Founder and CEO of Global-e. 'Interest in our global e-commerce solutions is as strong as ever, as we continue to help both new and existing merchants navigate a complex and dynamic environment. We remain on-track to achieve yet another year of solid top and bottom-line growth, in-line with our long-term targets, as is evident from our increased annual forecast.' Q2 2025 Financial Results GMV1 in the second quarter of 2025 was $1,454 million, an increase of 34% year over year Revenue in the second quarter of 2025 was $214.9 million, an increase of 28% year over year, of which service fees revenue was $102.9 million and fulfillment services revenue was $112 million Non-GAAP gross profit2 in the second quarter of 2025 was $99.9 million, an increase of 24% year over year. GAAP gross profit in the second quarter of 2025 was $97.7 million Non-GAAP gross margin2 in the second quarter of 2025 was 46.5%, compared with 47.8% in the second quarter of 2024. GAAP gross margin in the second quarter of 2025 was 45.5% Adjusted EBITDA3 in the second quarter of 2025 was $38.5 million compared to $31.3 million in the second quarter of 2024 Net profit in the second quarter of 2025 was $10.5 million compared to net loss of $22.4 million in the second quarter of 2024 Net cash from operating activities in the second quarter of 2025 was $65.0 million compared with $64.1 million in the second quarter of 2024 Free Cash Flow in the second quarter of 2025 was $63.5 million, compared with $63.5 million in the second quarter of 2024 Recent Business Highlights Continued launching brands across geographies and verticals, including: SteelSeries, a consumer technology company and GANNI, a fashion brand, both out of Denmark JAKI, a fashion brand, and Escentual, a beauty retailer, both out of the UK StadiumGoods, one of the premier global resellers of sneakers and streetwear out of the US Bandi Namco, a Japanese gaming and media conglomerate Nanushka, a Hungarian fashion brand, Global-e's first merchant based out of Hungary SKYLRK, the new fashion brand from Justin and Hailey Bieber Bally, the renowned Swiss luxury brand Life360, an exciting consumer tech merchant and Global-e's first subscription brand Expanded scope of business with a number of merchants, such as: Vuori, where we added multiple countries in Europe as well as Australia and Japan Bang & Olfson, Onitsuka Tiger and Diesel, where we added Hong Kong Bennett Winch, the luxury luggage brand, which used Global-e's services to enter into Taiwan Jones Road Beauty, the fast-growing make-up brand, where we added Central and Eastern Europe Extended Global-e's long-term strategic partnership with DHL, entering into another three-year agreement Acquired ReturnGo, a leading provider of AI-enabled return and exchange solutions Q3 2025 and Full Year Outlook Global-e is introducing third quarter guidance and is raising the full year guidance as follows: Q3 2025 FY 2025 Previous FY 2025 (in millions) GMV (1) $1,455 - $1,495 $6,220 - $6,520 $6,190 - $6,490 Revenue $214 - $221 $921.5 - $971.5 $917 - $967 Adjusted EBITDA (3) $37.5 - $41.5 $180 - $200 $179 - $199 1 Gross Merchandise Value (GMV) is a key operating metric. See 'Non-GAAP Financial Measures and Key Operating Metrics' for additional information regarding this metric. 2 Non-GAAP Gross profit and Non-GAAP gross margin are non-GAAP financial measures. See 'Non-GAAP Financial Measures and Key Operating Metrics' for additional information regarding this metric. 3 Adjusted EBITDA is a non-GAAP financial measure. See 'Non-GAAP Financial Measures' for additional information regarding this metric, including the reconciliations to Operating Profit (Loss), its most directly comparable GAAP financial measure. The Company is unable to provide a reconciliation of Adjusted EBITDA to Operating Profit (Loss), its most directly comparable GAAP financial measure, on a forward-looking basis without unreasonable effort because items that impact this GAAP financial measure are not within the Company's control and/or cannot be reasonably predicted. These items may include, but are not limited to, share-based compensation expenses. Such information may have a significant, and potentially unpredictable impact on the Company's future financial results. Conference Call Information: Global-e will host a conference call at 8:00 a.m. ET on Wednesday, August 13, call will be available, live, to interested parties by dialing: United States/Canada Toll Free: 1-800-717-1738 International Toll: 1-646-307-1865 A live webcast will also be available in the Investor Relations section of Global-E's website at: Approximately two hours after completion of the live call, an archived version of the webcast will be available on the Investor Relations section of the Company's web site and will remain available for approximately 30 calendar days. The press release with the financial results will be accessible on the Company's Investor Relations website prior to the conference call. Non-GAAP Financial Measures and Key Operating Metrics To supplement Global-e's financial information presented in accordance with generally accepted accounting principles in the United States of America, or GAAP, Global-e considers certain financial measures and key performance metrics that are not prepared in accordance with GAAP including: Non-GAAP gross profit, which Global-e defines as gross profit adjusted for amortization of acquired intangibles. Non-GAAP gross margin is calculated as Non-GAAP gross profit divided by revenues Adjusted EBITDA, which Global-e defines as operating profit (loss) adjusted for stock-based compensation expenses, depreciation and amortization, commercial agreements amortization, amortization of acquired intangibles, merger related contingent consideration and acquisition related expenses. Free Cash Flow, which Global-e defines as net cash provided by operating activities less the purchase of property and equipment. Global-e also uses Gross Merchandise Value (GMV) as a key operating metric. Gross Merchandise Value or GMV is defined as the combined amount we collect from the shopper and the merchant for all components of a given transaction, including products, duties and taxes and shipping. The aforementioned key performance indicators and non-GAAP financial measures are used, in conjunction with GAAP measures, by management and our board of directors to assess our performance, including the preparation of Global-e's annual operating budget and quarterly forecasts, for financial and operational decision-making, to evaluate the effectiveness of Global-e's business strategies, and as a means to evaluate period-to-period comparisons. These measures are frequently used by analysts, investors and other interested parties to evaluate companies in our industry. We believe that these non-GAAP financial measures are appropriate measures of operating performance because they remove the impact of certain items that we believe do not directly reflect our core operations, and permit investors to view performance using the same tools that we use to budget, forecast, make operating and strategic decisions, and evaluate historical performance. Global-e's definition of Non-GAAP measures may differ from the definition used by other companies and therefore comparability may be limited. In addition, other companies may not publish these metrics or similar metrics. Furthermore, these metrics have certain limitations in that they do not include the impact of certain expenses that are reflected in our consolidated statement of operations that are necessary to run our business. Thus, Non-GAAP measures should be considered in addition to, not as substitutes for, or in isolation from, measures prepared in accordance with GAAP. For more information on the non-GAAP financial measures, please see the reconciliation tables provided below. The accompanying reconciliation tables have more details on the GAAP financial measures that are most directly comparable to non-GAAP financial measures and the related reconciliations between these financial measures. Cautionary Note Regarding Forward Looking Statements This press release contains estimates and forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the 'Exchange Act'). All statements contained in this press release other than statements of historical fact, including, without limitation, statements regarding our future strategy and projected revenue, GMV, Adjusted EBITDA and other future financial and operational results, growth strategy and plans and objectives of management for future operations, including, among others, expansion in new and existing markets as well as anticipated trends and challenges in our business and the markets in which we operate, are forward-looking statements. As the words 'may,' 'might,' 'will,' 'could,' 'would,' 'should,' 'expect,' 'plan,' 'anticipate,' 'intend,' 'target,' 'seek,' 'believe,' 'estimate,' 'predict,' 'potential,' 'continue,' 'contemplate,' 'possible' or the negative of these terms or other similar expressions are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Global-e believes there is a reasonable basis for its expectations and beliefs, but they are inherently uncertain. Many factors could cause actual future events to differ materially from the forward-looking statements in this announcement, including but not limited to, our rapid growth and growth rates in recent periods may not be indicative of future growth; the ability to retain merchants or the GMV generated by such merchants; the ability to retain existing, and attract new merchants; our business acquisitions and ability to effectively integrate acquired businesses; our ability to anticipate merchant needs or develop or acquire new functionality or enhance our existing platforms to meet those needs; our ability to implement and use artificial intelligence and machine learning technologies successfully; our ability to compete in our industry; our reliance on third-parties, including our ability to realize the benefits of any strategic alliances, joint ventures, or partnership arrangements and to integrate our platforms with third-party platforms; our ability to develop or maintain the functionality of our platforms, including real or perceived errors, failures, vulnerabilities, or bugs in our platforms; our history of net losses; our ability to manage our growth and manage expansion into additional markets; increased attention to ESG matters and our ability to manage such matters; our ability to accommodate increased volumes during peak seasons and events; our ability to effectively expand our marketing and sales capabilities; our expectations regarding our revenue, expenses and operations; our ability to operate internationally; our reliance on third-party services, including third-party providers of cross-docking services and third-party data centers, in our platforms and services and harm to our reputation by our merchants' or third-party service providers' unethical business practices; our ability to adapt to changes in mobile devices, systems, applications, or web browsers that may degrade the functionality of our platforms; our operation as a merchant of record for sales conducted using our platform; regulatory requirements and additional fees related to payment transactions through our e-commerce platforms could be costly and difficult to comply with; compliance and third-party risks related to anti-money laundering, anti-corruption, anti-bribery, regulations, economic sanctions and export control laws and import regulations and restrictions; our business's reliance on the personal importation model; our ability to securely store personal information of merchants and shoppers; increases in shipping rates; fluctuations in the exchange rate of foreign currencies has impacted and could continue to impact our results of operations; our ability to offer high quality support; our ability to expand the number of merchants using our platforms and increase our GMV and to enhance our reputation and awareness of our platforms; our dependency on the continued use of the internet for commerce; our ability to adapt to emerging or evolving regulatory developments, changing laws, regulations, standards and technological changes related to privacy, data protection, data security and machine learning technology and generative artificial intelligence evolves; the effect of the situation in Ukraine on our business, financial condition and results of operations; our role in the fulfilment chain of the merchants, which may cause third parties to confuse us with the merchants; our ability to establish and protect intellectual property rights; and our use of open-source software which may pose particular risks to our proprietary software technologies; our dependency on our executive officers and other key employees and our ability to hire and retain skilled key personnel, including our ability to enforce non-compete agreements we enter into with our employees; litigation for a variety of claims which we may be subject to; the adoption by merchants of a direct to consumer model; our anticipated cash needs and our estimates regarding our capital requirements and our needs for additional financing; our ability to maintain our corporate culture; our ability to maintain an effective system of disclosure controls and internal control over financial reporting; our ability to accurately estimate judgments relating to our critical accounting policies; changes in tax laws or regulations to which we are subject, including the enactment of legislation implementing changes in taxation of international business activities and the adoption of other corporate tax reform policies; requirements to collect sales or other taxes relating to the use of our platforms and services in jurisdictions where we have not historically done so; global events such as war, health pandemics, climate change, macroeconomic events and the recent economic slowdown; risks relating to our ordinary shares, including our share price, the concentration of our share ownership with insiders, our status as a foreign private issuer, provisions of Israeli law and our amended and restated articles of association and actions of activist shareholders; risks related to our incorporation and location in Israel, including risks related to the ongoing war and related hostilities; and the other risks and uncertainties described in Global-e's Annual Report on Form 20-F for the year ended December 31, 2024, filed with the SEC on March 27, 2025 and other documents filed with or furnished by Global-e from time to time with the Securities and Exchange Commission (the 'SEC'). The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. These statements reflect management's current expectations regarding future events and operating performance and speak only as of the date of this press release. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or will occur. We undertake no obligation to update any forward-looking statements made in this press release to reflect events or circumstances after the date of this press release or to reflect new information or the occurrence of unanticipated events, except as required by law. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. About Global-E Online Ltd. Global-e (Nasdaq: GLBE) is the world's leading platform enabling and accelerating global, Direct-To-Consumer e-commerce. The chosen partner of over 1,400 brands and retailers across the North America, EMEA and APAC, Global-e makes selling internationally as simple as selling domestically. The company enables merchants to increase the conversion of international traffic into sales by offering online shoppers in over 200 destinations worldwide a seamless, localized shopping experience. Global-e's end-to-end e-commerce solutions combine best-in-class localization capabilities, big-data best-practice business intelligence models, streamlined international logistics and vast global e-commerce experience, enabling international shoppers to buy seamlessly online and retailers to sell to, and from, anywhere in the world. For more information, please visit: Investor Contact:Alan KatzGlobal-e Investor RelationsIR@ Press Contact:Sarah SchlossHeadline MediaGlobale@ +1 786-233-7684 Global-E Online BALANCE SHEETS(In thousands) Period Ended December 31, June 30, 2024 2025 (Audited) (Unaudited) Assets Current assets: Cash and cash equivalents $ 254,620 $ 205,230 Short-term deposits 183,475 254,612 Accounts receivable, net 41,171 30,177 Prepaid expenses and other current assets 84,613 96,987 Marketable securities 36,345 55,641 Funds receivable, including cash in banks 122,984 92,376 Total current assets 723,208 735,023 Property and equipment, net 10,440 11,321 Operating lease right-of-use assets 24,429 22,405 Deferred contract acquisition and fulfillment costs, noncurrent 3,787 3,978 Long-term investments and other long-term assets 8,313 8,510 Commercial agreement asset 66,527 16,583 Goodwill 367,566 367,566 Intangible assets, net 59,212 50,408 Total long-term assets 540,274 480,771 Total assets $ 1,263,482 $ 1,215,794 Liabilities and Shareholders' Equity Current liabilities: Accounts payable $ 79,559 $ 52,860 Accrued expenses and other current liabilities 141,551 135,603 Funds payable to Customers 122,984 92,376 Short term operating lease liabilities 4,347 4,702 Total current liabilities 348,441 285,541 Long-term liabilities: Long term operating lease liabilities 20,510 19,945 Other long-term liabilities 1,098 1,223 Total liabilities $ 370,049 $ 306,709 Shareholders' equity: Share capital and additional paid-in capital 1,425,317 1,444,618 Accumulated comprehensive income (loss) 515 4,231 Accumulated deficit (532,399 ) (539,764 ) Total shareholders' equity 893,433 909,085 Total liabilities and shareholders' equity $ 1,263,482 $ 1,215,794 Global-E Online STATEMENTS OF OPERATIONS(In thousands, except share and per share data) Three Months Ended Six Months Ended June 30, June 30, 2024 2025 2024 2025 (Unaudited) (Unaudited) Revenue $ 168,008 $ 214,877 $ 313,881 $ 404,759 Cost of revenue 90,578 117,206 173,165 223,004 Gross profit 77,430 97,671 140,716 181,755 Operating expenses: Research and development 26,676 30,733 50,214 58,871 Sales and marketing 60,089 43,957 117,044 107,895 General and administrative 13,482 12,468 25,536 23,661 Total operating expenses 100,247 87,158 192,794 190,427 Operating profit (loss) (22,817 ) 10,513 (52,078 ) (8,672 ) Financial expenses (income), net 693 (978 ) 4,203 (2,848 ) Profit (loss) before income taxes (23,510 ) 11,491 (56,281 ) (5,824 ) Income taxes (1,068 ) 1,000 (1,788 ) 1,541 Net profit (loss) attributable to ordinary shareholders $ (22,442 ) $ 10,491 $ (54,493 ) $ (7,365 ) Net profit (loss) per share attributable to ordinary shareholders, basic $ (0.13 ) $ 0.06 $ (0.33 ) $ (0.04 ) Net profit (loss) per share attributable to ordinary shareholders, diluted $ (0.13 ) $ 0.06 $ (0.33 ) $ (0.04 ) Weighted-average shares used in computing net loss per share attributable to ordinary shareholders, basic 166,982,796 169,788,923 166,585,110 169,569,068 Weighted-average shares used in computing net loss per share attributable to ordinary shareholders, diluted 166,982,796 175,588,437 166,585,110 169,569,068 Global-E Online STATEMENTS OF CASH FLOWS(In thousands) Three Months Ended Six Months Ended June 30, June 30, 2024 2025 2024 2025 (Unaudited) (Unaudited) Operating activities Net profit (loss) $ (22,442 ) $ 10,491 $ (54,493 ) $ (7,365 ) Adjustments to reconcile net profit (loss) to net cash provided by operating activities: Depreciation 530 571 1,041 1,107 Share-based compensation expense 11,201 10,058 19,912 18,851 Commercial agreement asset 37,433 12,927 73,729 49,944 Amortization of intangible assets 5,000 4,402 10,002 8,804 Changes in accrued interest and exchange rate on short-term deposits (411 ) (1,383 ) (43 ) (2,225 ) Unrealized loss (gain) on foreign currency 584 (6,045 ) 3,310 (7,522 ) Accounts receivable (10,918 ) 4,523 (2,500 ) 10,994 Prepaid expenses and other assets 10,580 23,615 13,267 (4,790 ) Funds receivable 1,386 (3,884 ) (6,302 ) (13,066 ) Long-term investments and other receivables (229 ) (298 ) 481 (197 ) Funds payable to customers 18,084 4,893 (12,773 ) (30,607 ) Operating lease ROU assets 857 960 1,674 2,024 Deferred contract acquisition costs (367 ) (210 ) (635 ) (311 ) Accounts payable 2,135 (14,324 ) (14,914 ) (26,699 ) Accrued expenses and other liabilities 13,229 17,887 (16,999 ) (5,823 ) Deferred taxes (1,438 ) - (2,862 ) - Operating lease liabilities (1,099 ) 773 (2,043 ) (210 ) Net cash provided by (used in) operating activities 64,117 64,956 9,852 (7,091 ) Investing activities Investment in marketable securities (685 ) (1,911 ) (1,727 ) (19,679 ) Proceeds from marketable securities 399 699 1,411 1,698 Purchases of short-term investments (31,295 ) (114,000 ) (88,244 ) (184,972 ) Purchases of long-term investments (1,121 ) - (1,152 ) - Proceeds from short-term investments 36,250 44,000 94,250 111,059 Purchases of property and equipment (573 ) (1,440 ) (1,455 ) (1,988 ) Net cash provided by (used in) investing activities 2,975 (72,652 ) 3,083 (93,882 ) Financing activities Exercise of Warrants to ordinary shares 2 - 2 - Proceeds from exercise of share options 933 191 1,053 401 Net cash provided by financing activities 935 191 1,055 401 Exchange rate differences on balances of cash, cash equivalents and restricted cash (584 ) 6,045 (3,310 ) 7,522 Net increase (decrease) in cash, cash equivalents, and restricted cash 67,443 (1,460 ) 10,680 (93,050 ) Cash and cash equivalents and restricted cash—beginning of period 211,834 240,092 268,597 331,682 Cash and cash equivalents and restricted cash—end of period $ 279,277 $ 238,632 $ 279,277 $ 238,632 Global-E Online OTHER DATA(In thousands) Three Months Ended Six Months Ended June 30, June 30, 2024 2025 2024 2025 (Unaudited) (Unaudited) Key performance metrics Gross Merchandise Value 1,082,037 1,453,884 2,011,548 2,696,398 Adjusted EBITDA (a) 31,347 38,471 52,606 70,034 Revenue by Category Service fees 82,235 49 % 102,853 48 % 150,494 44 % 186,836 46 % Fulfillment services 85,773 51 % 112,024 52 % 163,387 56 % 217,923 54 % Total revenue $ 168,008 100 % $ 214,877 100 % $ 313,881 100 % $ 404,759 100 % Revenue by merchant outbound region United States 87,631 52 % 117,483 55 % 159,743 49 % 218,037 54 % United Kingdom 44,424 27 % 41,474 19 % 85,700 31 % 83,221 21 % European Union 26,773 16 % 38,738 18 % 53,117 17 % 72,268 18 % Israel 313 0 % 416 0 % 629 0 % 817 0 % Other 8,867 5 % 16,766 8 % 14,692 3 % 30,416 7 % Total revenue $ 168,008 100 % $ 214,877 100 % $ 313,881 100 % $ 404,759 100 % (a) See reconciliation to adjusted EBITDA table Global-E Online TO Non-GAAP GROSS PROFIT(In thousands) Three Months Ended Six Months Ended June 30, June 30, 2024 2025 2024 2025 (Unaudited) Gross Profit 77,430 97,671 140,716 181,755 Amortization of acquired intangibles included in cost of revenue 2,796 2,198 5,592 4,395 Non-GAAP gross profit 80,226 99,869 146,308 186,150 Global-E Online TO Free Cash Flow(In thousands) Three Months Ended Six Months Ended June 30, June 30, 2024 2025 2024 2025 (Unaudited) Net profit (loss) (22,442 ) 10,491 (54,493 ) (7,365 ) Income tax (benefit) expenses (1,068 ) 1,000 (1,788 ) 1,541 Financial expenses (income), net 693 (978 ) 4,203 (2,848 ) Stock-based compensation: Cost of revenue 180 254 360 520 Research and development 5,497 4,501 8,965 8,128 Selling and marketing 1,482 1,633 2,764 3,070 General and administrative 4,042 3,670 7,823 7,133 Total stock-based compensation 11,201 10,058 19,912 18,851 Depreciation and amortization 530 571 1,041 1,107 Commercial agreement asset amortization 37,433 12,927 73,729 49,944 Amortization of acquired intangibles 5,000 4,402 10,002 8,804 Adjusted EBITDA 31,347 38,471 52,606 70,034 Global-E Online TO Free Cash Flow(In thousands) Three Months Ended Six Months Ended June 30, June 30, 2024 2025 2024 2025 (Unaudited) (Unaudited) Net cash (used in) provided by operating activities 64,117 64,956 9,852 (7,091 ) Purchase of property and equipment (573 ) (1,440 ) (1,455 ) (1,988 ) Free Cash Flow 63,544 63,516 8,397 (9,079 )
Yahoo
10 minutes ago
- Yahoo
Greenwich LifeSciences Announces Expansion of Flamingo-01 into Romania
STAFFORD, Texas, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today announced the addition of clinical sites in Romania. The Company's application to expand Flamingo-01 into Romania has been formally approved by European regulators, thus adding Romanian sites to the approximately 150 approved sites in Spain, France, Germany, Italy, Poland and the US. At present, there are approximately 123 actively enrolling sites globally. According to the latest data collected by the European Cancer Information System (click here), a total of 12,861 new cases of breast cancer were diagnosed in Romania in 2022, which is the most common cancer diagnosed in women, representing approximately 28% of all cancers in women. Breast cancer is the leading cause of death from cancer in women in Romania with 3,877 deaths in 2022. The Company is collaborating with Dr. Nicoleta Antone, who is leading one of the largest academic breast cancer focused centers in Cluj Napoca, Romania, and her colleagues from at least 3 other sites in Romania. The Romanian clinical sites will be listed here with an interactive map. Dr. Antone will be serving as the national principal investigator in Romania for FLAMINGO-01. She is Head of Breast Cancer Centre at the Chiricuta Institute of Oncology in Cluj Napoca, Romania. She has been the Chair of the Romania Breast Cancer Group since 2021 and a member of the Women's Empowerment Cancer Advocacy Network since 2015. CEO Snehal Patel commented, "Romania is the first of several additional countries in Europe that we hope to add to Flamingo-01 as we now focus on mid-sized population countries with large population centers. We have visited the sites in Romania multiple times to assess study feasibility and provide training, and we are impressed with their facilities and commitment to the study. We look forward to working with Dr. Antone and her colleagues and have sufficiently advanced start-up activities this summer to be potentially screening and enrolling our first Romanian patients in the coming months." About FLAMINGO-01 and GLSI-100 FLAMINGO-01 (NCT05232916) is a Phase III clinical trial designed to evaluate the safety and efficacy of GLSI-100 (GP2 + GM-CSF) in HER2 positive breast cancer patients who had residual disease or high-risk pathologic complete response at surgery and who have completed both neoadjuvant and postoperative adjuvant trastuzumab based treatment. The trial is led by Baylor College of Medicine and currently includes US and European clinical sites from university-based hospitals and academic and cooperative networks with plans to open up to 150 sites globally. In the double-blinded arms of the Phase III trial, approximately 500 HLA-A*02 patients will be randomized to GLSI-100 or placebo, and up to 250 patients of other HLA types will be treated with GLSI-100 in a third arm. The trial has been designed to detect a hazard ratio of 0.3 in invasive breast cancer-free survival, where 28 events will be required. An interim analysis for superiority and futility will be conducted when at least half of those events, 14, have occurred. This sample size provides 80% power if the annual rate of events in placebo-treated subjects is 2.4% or greater. For more information on FLAMINGO-01, please visit the Company's website here and here. Contact information and an interactive map of the majority of participating clinical sites can be viewed under the "Contacts and Locations" section. Please note that the interactive map is not viewable on mobile screens. Related questions and participation interest can be emailed to: flamingo-01@ About Breast Cancer and HER2/ Positivity One in eight U.S. women will develop invasive breast cancer over her lifetime, with approximately 300,000 new breast cancer patients and 4 million breast cancer survivors. HER2 (human epidermal growth factor receptor 2) protein is a cell surface receptor protein that is expressed in a variety of common cancers, including in 75% of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels. About Greenwich LifeSciences, Inc. Greenwich LifeSciences is a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery. GP2 is a 9 amino acid transmembrane peptide of the HER2 protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in 75% of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels. Greenwich LifeSciences has commenced a Phase III clinical trial, FLAMINGO-01. For more information on Greenwich LifeSciences, please visit the Company's website at and follow the Company's Twitter at Forward-Looking Statement Disclaimer Statements in this press release contain "forward-looking statements" that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as "anticipate," "believe," "contemplate," "could," "estimate," "expect," "intend," "seek," "may," "might," "plan," "potential," "predict," "project," "target," "aim," "should," "will," "would," or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on Greenwich LifeSciences Inc.'s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict, including statements regarding the intended use of net proceeds from the public offering; consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. These and other risks and uncertainties are described more fully in the section entitled "Risk Factors" in Greenwich LifeSciences' Annual Report on the most recent Form 10-K for the year ended December 31, 2024, and other periodic reports filed with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date, and Greenwich LifeSciences, Inc. undertakes no duty to update such information except as required under applicable law. Company ContactSnehal PatelInvestor RelationsOffice: (832) 819-3232Email: info@ Investor & Public Relations Contact for Greenwich LifeSciencesDave GentryRedChip Companies 1-800-RED CHIP (733 2447)Email: dave@ in to access your portfolio
Yahoo
10 minutes ago
- Yahoo
High Growth Tech Stocks to Watch in August 2025
As global markets navigate a complex landscape marked by the Bank of England's rate cut and the Nasdaq Composite reaching an all-time high, investors are closely watching how these dynamics impact technology stocks. In such an environment, identifying high-growth tech stocks requires a keen understanding of market trends and economic indicators that can influence small-cap companies, making it crucial to focus on innovation potential and resilience in fluctuating conditions. Top 10 High Growth Tech Companies Globally Name Revenue Growth Earnings Growth Growth Rating Shanghai Huace Navigation Technology 25.38% 24.34% ★★★★★★ Intellego Technologies 28.42% 47.04% ★★★★★★ Gold Circuit Electronics 26.63% 32.83% ★★★★★★ eWeLLLtd 24.95% 24.40% ★★★★★★ KebNi 20.56% 65.02% ★★★★★★ Nayax 22.26% 57.43% ★★★★★★ Shengyi Electronics 26.23% 37.08% ★★★★★★ Hacksaw 26.01% 37.60% ★★★★★★ CD Projekt 33.65% 39.46% ★★★★★★ CARsgen Therapeutics Holdings 81.53% 96.08% ★★★★★★ Click here to see the full list of 234 stocks from our Global High Growth Tech and AI Stocks screener. We're going to check out a few of the best picks from our screener tool. Skyworth Digital Simply Wall St Growth Rating: ★★★★☆☆ Overview: Skyworth Digital Co., Ltd. is a company that manufactures and sells home video entertainment and intelligent connectivity solutions globally, with a market cap of CN¥13.44 billion. Operations: Skyworth Digital Co., Ltd. focuses on producing and distributing home video entertainment systems and smart connectivity solutions across global markets. The company's operations are supported by its significant market presence, reflected in a market capitalization of CN¥13.44 billion. Skyworth Digital, navigating a challenging tech landscape, demonstrates robust future potential with an expected annual earnings growth of 43.6%, significantly outpacing the Chinese market's average of 23.8%. This growth is supported by high-quality past earnings and a promising increase in R&D investment, which now stands at 5% of their total revenue. Despite a slowdown with only a 13.3% revenue growth rate compared to the industry's faster pace, the company maintains its competitive edge through strategic investments in innovation and technology development. Moreover, Skyworth's commitment to expanding its technological capabilities could potentially reshape its market standing and fuel long-term growth amidst fluctuating profit margins which currently linger at 1.8%. Delve into the full analysis health report here for a deeper understanding of Skyworth Digital. Learn about Skyworth Digital's historical performance. Kamada Simply Wall St Growth Rating: ★★★★☆☆ Overview: Kamada Ltd. is a company that focuses on the production and distribution of plasma-derived protein therapeutics, with a market capitalization of ₪1.46 billion. Operations: Kamada generates revenue primarily through two segments: Proprietary Products, contributing $147.71 million, and Distribution, adding $19.53 million. Kamada's recent FDA approval for its Houston plasma collection center marks a strategic expansion in the U.S. market, complementing its robust portfolio of FDA-approved specialty products and biosimilars aimed at unmet medical needs. With a Q1 revenue increase to $44.02 million from $37.74 million year-over-year and net income rising to $3.96 million from $2.37 million, Kamada is not just enhancing its infrastructure but also showing solid financial growth. The company's R&D commitment is evident in its InnovAATe clinical trial progress, positioning it well within the biotech sector where it has outpaced industry earnings growth by 28.9% compared to the industry's 10.9%. Take a closer look at Kamada's potential here in our health report. Gain insights into Kamada's past trends and performance with our Past report. oRo Simply Wall St Growth Rating: ★★★★☆☆ Overview: oRo Co., Ltd. is a Japanese company specializing in cloud and digital transformation solutions, with a market capitalization of approximately ¥51.31 billion. Operations: The company generates revenue primarily through its Cloud Solution Business, contributing ¥5.11 billion, and Marketing Solutions, adding ¥2.85 billion. oRo Co., Ltd. is demonstrating robust growth dynamics, particularly in its software division which continues to outpace general market trends with an 18.6% annual revenue increase, significantly higher than the JP market's 4.3%. This growth is underpinned by aggressive R&D investments, accounting for a substantial portion of revenue; specifically, R&D expenses have surged to $200 million this year alone. Additionally, the company's strategic share repurchase program has seen it buy back 127,800 shares for ¥349.56 million recently, reflecting a strong commitment to enhancing shareholder value and capital efficiency. With earnings expected to grow by 22.4% annually—more than double the industry average—oRo stands well-positioned within the tech sector amid evolving digital landscapes. Get an in-depth perspective on oRo's performance by reading our health report here. Understand oRo's track record by examining our Past report. Taking Advantage Unlock our comprehensive list of 234 Global High Growth Tech and AI Stocks by clicking here. Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments. Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide. Ready For A Different Approach? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SZSE:000810 TASE:KMDA and TSE:3983. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
